125 related articles for article (PubMed ID: 11035243)
1. In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibiotics.
Giacometti A; Cirioni O; Barchiesi F; Scalise G
Diagn Microbiol Infect Dis; 2000 Oct; 38(2):115-8. PubMed ID: 11035243
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity and killing effect of the synthetic hybrid cecropin A-melittin peptide CA(1-7)M(2-9)NH(2) on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics.
Giacometti A; Cirioni O; Kamysz W; D'Amato G; Silvestri C; Simona Del Prete M; Lukasiak J; Scalise G
Diagn Microbiol Infect Dis; 2004 Jul; 49(3):197-200. PubMed ID: 15246510
[TBL] [Abstract][Full Text] [Related]
3. A combination of silver nanoparticles and visible blue light enhances the antibacterial efficacy of ineffective antibiotics against methicillin-resistant Staphylococcus aureus (MRSA).
Akram FE; El-Tayeb T; Abou-Aisha K; El-Azizi M
Ann Clin Microbiol Antimicrob; 2016 Aug; 15(1):48. PubMed ID: 27530257
[TBL] [Abstract][Full Text] [Related]
4. In-vitro activity and killing effect of quinupristin/dalfopristin (RP59500) on nosocomial Staphylococcus aureus and interactions with rifampicin and ciprofloxacin against methicillin-resistant isolates.
Sambatakou H; Giamarellos-Bourboulis EJ; Grecka P; Chryssouli Z; Giamarellou H
J Antimicrob Chemother; 1998 Mar; 41(3):349-55. PubMed ID: 9578161
[TBL] [Abstract][Full Text] [Related]
5. In vitro bactericidal activity of peak serum concentrations of co-amoxiclav, amoxicillin and vancomycin against methicillin-resistant Staphylococcus aureus.
Gómez-Lus ML; Prieto J; Giménez MJ; García M; Anta L; Aguilar L
Rev Esp Quimioter; 1999 Jun; 12(2):136-9. PubMed ID: 10562674
[TBL] [Abstract][Full Text] [Related]
6. In vitro activities of nisin alone or in combination with vancomycin and ciprofloxacin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains.
Dosler S; Gerceker AA
Chemotherapy; 2011; 57(6):511-6. PubMed ID: 22302084
[TBL] [Abstract][Full Text] [Related]
7. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan.
Naimi HM; Rasekh H; Noori AZ; Bahaduri MA
BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146
[TBL] [Abstract][Full Text] [Related]
8. Nisin, alone and combined with peptidoglycan-modulating antibiotics: activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
Brumfitt W; Salton MR; Hamilton-Miller JM
J Antimicrob Chemother; 2002 Nov; 50(5):731-4. PubMed ID: 12407132
[TBL] [Abstract][Full Text] [Related]
9. In vitro activities of polycationic peptides alone and in combination with clinically used antimicrobial agents against Rhodococcus equi.
Giacometti A; Cirioni O; Ancarani F; Del Prete MS; Fortuna M; Scalise G
Antimicrob Agents Chemother; 1999 Aug; 43(8):2093-6. PubMed ID: 10428947
[TBL] [Abstract][Full Text] [Related]
10. In Vitro Antistaphylococcal Synergistic Effect of Isoflavone Metabolite Demethyltexasin with Amoxicillin and Oxacillin.
Rondevaldova J; Hummelova J; Tauchen J; Kokoska L
Microb Drug Resist; 2018; 24(1):24-29. PubMed ID: 28570834
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity effects of combinations of cephalothin, dicloxacillin, imipenem, vancomycin and amikacin against methicillin-resistant Staphylococcus spp. strains.
Miranda-Novales G; Leaños-Miranda BE; Vilchis-Pérez M; Solórzano-Santos F
Ann Clin Microbiol Antimicrob; 2006 Oct; 5():25. PubMed ID: 17034644
[TBL] [Abstract][Full Text] [Related]
12. Vancomycin and piperacillin-tazobactam against methicillin-resistant Staphylococcus aureus and vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model.
Dilworth TJ; Leonard SN; Vilay AM; Mercier RC
Clin Ther; 2014 Oct; 36(10):1334-44. PubMed ID: 25066667
[TBL] [Abstract][Full Text] [Related]
13. Potent, synergistic inhibition of Staphylococcus aureus upon exposure to a combination of the endopeptidase lysostaphin and the cationic peptide ranalexin.
Graham S; Coote PJ
J Antimicrob Chemother; 2007 Apr; 59(4):759-62. PubMed ID: 17324959
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of mupirocin and amoxicillin-clavulanate alone and in combination against staphylococci including those resistant to methicillin.
Alou L; Cafini F; Sevillano D; Unzueta I; Prieto J
Int J Antimicrob Agents; 2004 May; 23(5):513-6. PubMed ID: 15120734
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Single and Combined Antibiotic Treatments of Anthrax in Rabbits.
Weiss S; Altboum Z; Glinert I; Schlomovitz J; Sittner A; Bar-David E; Kobiler D; Levy H
Antimicrob Agents Chemother; 2015 Dec; 59(12):7497-503. PubMed ID: 26392505
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
Ishag AJ; Durgham SM; Shibl AM
Chemioterapia; 1987 Aug; 6(4):261-3. PubMed ID: 3477333
[TBL] [Abstract][Full Text] [Related]
17. In-vitro activity of moxifloxacin combined with other antibacterials against methicillin-resistant Staphylococcus aureus.
Maggiolo F; Capra R; Bottura P; Pravettoni G; Migliorino M; Suter F
J Chemother; 2000 Jun; 12(3):195-8. PubMed ID: 10877512
[TBL] [Abstract][Full Text] [Related]
18. In vitro activities of ciprofloxacin and rifampin alone and in combination against growing and nongrowing strains of methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
Bahl D; Miller DA; Leviton I; Gialanella P; Wolin MJ; Liu W; Perkins R; Miller MH
Antimicrob Agents Chemother; 1997 Jun; 41(6):1293-7. PubMed ID: 9174186
[TBL] [Abstract][Full Text] [Related]
19. In vitro activities of antimicrobial cationic peptides; melittin and nisin, alone or in combination with antibiotics against Gram-positive bacteria.
Dosler S; Gerceker AA
J Chemother; 2012 Jun; 24(3):137-43. PubMed ID: 22759757
[TBL] [Abstract][Full Text] [Related]
20. The rapid emergence of fluoroquinolone-methicillin-resistant Staphylococcus aureus infections in a community hospital. An in vitro look at alternative antimicrobial agents.
Aldridge KE; Gelfand MS; Schiro DD; Barg NL
Diagn Microbiol Infect Dis; 1992; 15(7):601-8. PubMed ID: 1424517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
